This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Olga V Vladimirova: Innovator in Cell Aging and Carcinogenesis
Introduction
Olga V Vladimirova is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of cell biology, particularly in the regulation of cell aging and carcinogenesis. Her innovative work has led to the development of methods and compositions that have the potential to impact medical science and treatment strategies.
Latest Patents
Olga holds a patent for "Methods and compositions for regulation of cell aging, carcinogenesis and reprogramming." This patent describes compositions and methods that include somatic cells competent for reprogramming and malignant transformation. These cells are characterized by a reduction of Sp100 levels, which plays a crucial role in the regulation of aging and reprogramming to pluripotency. The methods outlined in her patent involve modulating the expression of Sp100 to regulate aging or reprogramming in somatic cells. Additionally, her work includes methods for treating proliferative diseases by increasing the expression of Sp100 in targeted cells.
Career Highlights
Olga V Vladimirova is affiliated with The Wistar Institute of Anatomy & Biology, where she conducts her research. Her work has garnered attention for its innovative approach to understanding cell behavior and its implications for treating various diseases.
Collaborations
Olga has collaborated with notable colleagues, including Gerd G Maul and Dmitri G Negorev. These collaborations have further enriched her research and contributed to advancements in the field.
Conclusion
Olga V Vladimirova is a trailblazer in the realm of cell biology, with her patent reflecting her commitment to advancing scientific knowledge and medical applications. Her innovative methods hold promise for future research and therapeutic strategies in combating cell aging and cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
